Skip to main content

Recombinant Human B4GalT1 (Y285L) Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 7040-GT

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
7040-GT-010

Key Product Details

Source

NS0

Accession #

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human beta-1,4-Galactosyltransferase 1/B4GalT1 protein
Gly44-Ser398, with an N-terminal 6-His tag and a Y285L mutation

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

His

Predicted Molecular Mass

40 kDa

SDS-PAGE

45-60 kDa, reducing conditions

Activity

Measured by its ability to transfer N-Acetyl-D-galactosamine from UDP-GalNAc to N-Acetyl-D-glucosamine.
The specific activity is >2,000 pmol/min/μg, as measured under the described conditions.

Formulation, Preparation and Storage

7040-GT
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and TCEP.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: beta-1,4-Galactosyltransferase 1/B4GalT1

beta‑1,4‑Galactosyltransferase 1, also known as B4GalT1, is one of seven beta‑1,4 galactosyltransferases that transfer galactose to acceptor sugars including GlcNAc, Glc and Xyl (1, 2). A single point mutation, Y285L, in beta4GalT1 causes a functional switch in activity from Gal‑transferase activity to GalNAc‑transferase activity (3).The recombinant human B4GalT1(Y285L) can be used to synthesize lacdiNAc-terminated glycoconjugates, terminal glycan modifications found on many glycoproteins, including activation receptors of natural killer cells, NKR-P1 and CD69 (4). The enzymatic activity of the recombinant human B4GalT1 (Y285L) was assayed using a phosphatase-coupled method (5).

References

  1. Guo, S. et al. (2001) Glycobiology 11:813.
  2. Yamaguchi, N. and Fukuda, M.N. (1995) J. Biol. Chem. 270:12170.
  3. Ramakrishnan, B. and Qasba, P.K. (2002) J. Biol. Chem. 277:20833.
  4. Do, K.Y. et al. (1997) Glycobiology 7:183.
  5. Wu, Z.L. et al. (2011) Glycobiology 21:727.

Long Name

UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, Polypeptide 1

Alternate Names

GGTB2

Entrez Gene IDs

2683 (Human); 14595 (Mouse); 24390 (Rat)

Gene Symbol

B4GALT1

UniProt

Additional beta-1,4-Galactosyltransferase 1/B4GalT1 Products

Product Documents for Recombinant Human B4GalT1 (Y285L) Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human B4GalT1 (Y285L) Protein, CF

For research use only

Loading...
Loading...
Loading...